SRRK:NASDAQ, Scholar Rock Holding Corporation

SRRK stock overview

Scholar Rock Holding Corporation (SRRK:NASDAQ) closed at $43.21 on November 13, 2026, up 0.10% on the day. The stock trades 30.0% below its 52-week high of $61.76 and 26.1% above its 52-week low of $34.25. Over the past year, it gained 15.5%. Scholar Rock Holding Corporation is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).

Key figures

Price: $43.21
Day change: +0.10%
Volume: 623,503
Average volume: 1,763,710
Market cap: 5B+
52-week range: $34.25 – $61.76
50-day average: $46.38
200-day average: $48.25

Price action over the past year

In 252 trading sessions since November 13, 2025, SRRK closed higher on 122 days (48%). Its best day was November 14, 2025 (+24.41%) and its worst was November 12, 2026 (-7.38%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Nov 10, 2026: News catalyst: Earnings (News Catalysts scanner)

SRRK news

Nov 14, 2026: Biotech Dealmaker: Early-Stage Platforms And Tools Draw Capital As Full Buyouts Remain On The Sidelines This Week
Nov 13, 2026: Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 10, 2026: Scholar Rock (SRRK) Q3 2026 Earnings Call Transcript
Nov 10, 2026: What Scholar Rock (SRRK) Said on Its Q3 Earnings Call
Nov 10, 2026: Scholar Rock Beats On Narrower Per-Share Loss As ISEMBYLD Launch Begins, But Revenue Ramp Will Lag Demand
Nov 10, 2026: What Scholar Rock Holding (SRRK)'s ISEMBYLD Launch Means For Shareholders
Nov 10, 2026: Scholar Rock Holding Corporation (SRRK) Reports Q3 Loss, Beats Revenue Estimates
Nov 10, 2026: Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Business Highlights

About Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.

Similar stocks

Find more stocks like SRRK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.